ProVerum

Dublin, Ireland · Biotechnology, Health Care · 49 employees

ProVerum develops minimally invasive technologies to treat BPH. Its first product offering, the ProVee System for BPH is an investigational device that uses a nitinol stent designed to gently re-shape the enlarged BPH prostate and alleviate the associated lower urinary tract symptoms. It is deployed through a low profile, flexible, steerable delivery system with integrated imaging, which is the sa

See plans & pricing → Track ProVerum’s funding, hiring, and signals — with verified contacts — on Fundz.